← Back to Search

Virus Therapy

STRI Formula for Coronavirus

Phase 2
Recruiting
Led By Rama D Jager, MD
Research Sponsored by Eyecheck, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This trial will test whether a new formula can help people with COVID-19.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Length of time from treatment initiation to initial meaningful clinical improvement as measured over 30 days.
Secondary outcome measures
Length of time from treatment initiation to initial clinical recovery.
Therapeutic procedure
Length of time from treatment initiation to sustained meaningful clinical improvement.
+9 more
Other outcome measures
Proportion of participants with PCR positivity for SARS-CoV-2 at 5, 10, 15, and 30 in saliva samples (first-stage only) compared to Day 1 (before treatment initiation)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: STRI FormulaActive Control1 Intervention
STRI Formula 3 capsules by mouth twice daily for 10 days
Group II: PlaceboPlacebo Group1 Intervention
Placebo 3 capsules by mouth twice daily for 10 days

Find a Location

Who is running the clinical trial?

Eyecheck, Inc.Lead Sponsor
Rama D Jager, MDPrincipal InvestigatorEyecheck, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many different medical clinics are conducting this clinical trial?

"Currently, there are 14 medical facilities recruiting patients for this trial. These locations include Prohealth Research Center in Doral, Davila Medical Research in Miami, and A&A Research Group in Coral Gables; just to list a few of the participating centres."

Answered by AI

Are medical professionals currently recruiting patients for this clinical trial?

"Yes, this study is looking for volunteers who match the eligibility criteria. The listing on clinicaltrials.gov shows that the trial was first posted on November 4th 2021 and last updated September 8th 2022."

Answered by AI

Is it dangerous to take STRI Formula?

"Given that this is a Phase 2 trial - meaning that while there is some data supporting safety, none supports efficacy - our team at Power has given STRI Formula a score of 2 for safety."

Answered by AI

How big is the sample size for this experiment?

"Yes, according to the clinicaltrials.gov website, this trial is looking for patients as we speak. The posting date was November 4th 2021 and the last edit occurred on September 8th 2022. They are recruiting 598 people from 14 different locations."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
2021. "Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05046561.
~175 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top